Use of Vasopressin Following the Fontan Operation

• Status: Suspended
• Trial end date: 2019-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether Vasopressin following the Fontan operation will decrease chest tube output and duration.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Advocate Health Care
• Treatments: Arginine Vasopressin; Polystyrene sulfonic acid; Vasopressins

Criteria

Inclusion Criteria:

• Subjects between 1.5-7 years old undergoing Fontan operation.

Exclusion Criteria:

• Patients with a planned fenestrated Fontan.

• Patients undergoing revision surgery for failing Fontan.

• Evidence of renal insufficiency prior to surgery defined by creatinine >1 mg/dl.

• Planned arch reconstruction at the time of the Fontan procedure